ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cellectis Nom Eo 05

Cellectis Nom Eo 05 (ALCLS)

1.514
-0.026
(-1.69%)
終了 1月21日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
1.514
買値
1.514
売値
1.536
出来高
37,390
1.504 日の範囲 1.554
1.414 52 週間の範囲 3.025
時価総額
前日終値
1.54
始値
1.54
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
61,343
発行済株式数
45,874,895
配当利回り
-
PER
-0.69
1 株当たり利益 (EPS)
-2.2
歳入
9.24M
純利益
-101.06M

Cellectis Nom Eo 05 について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Paris, Paris, Fra
設立
-
Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.54 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 1.414 € to 3.025 €.

Cellectis Nom Eo 05 currently has 45,874,895 shares in issue. The market capitalisation of Cellectis Nom Eo 05 is 70.65 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -0.69.

ALCLS 最新ニュース

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 08...

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB) NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE...

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform...

Cellectis annonce le tirage de la troisième tranche de 5 millions d’euros dans le cadre du contrat de crédit conclu avec la Banque Européenne d’Investissement (BEI)

Cellectis annonce le tirage de la troisième tranche de 5 millions d’euros dans le cadre du contrat de crédit conclu avec la Banque Européenne d’Investissement (BEI) NEW YORK , 10 déc. 2024...

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 04...

Monthly information on share capital and company voting rights

Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Listing...

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 06 nov...

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.304-16.72167216721.8181.8181.504529271.62581394DE
4-0.004-0.2635046113311.5182.081.442935951.72682189DE
12-0.246-13.97727272731.762.081.414613431.73454938DE
26-0.382-20.14767932491.8962.171.414503191.82073213DE
52-0.906-37.43801652892.423.0251.414727682.19962045DE
156-4.496-74.80865224636.016.2950.8881587612.77707394DE
260-14.996-90.829800121116.5128.450.8881420726.4024676DE

ALCLS - Frequently Asked Questions (FAQ)

What is the current Cellectis Nom Eo 05 share price?
The current share price of Cellectis Nom Eo 05 is 1.514 €
How many Cellectis Nom Eo 05 shares are in issue?
Cellectis Nom Eo 05 has 45,874,895 shares in issue
What is the market cap of Cellectis Nom Eo 05?
The market capitalisation of Cellectis Nom Eo 05 is EUR 70.65M
What is the 1 year trading range for Cellectis Nom Eo 05 share price?
Cellectis Nom Eo 05 has traded in the range of 1.414 € to 3.025 € during the past year
What is the PE ratio of Cellectis Nom Eo 05?
The price to earnings ratio of Cellectis Nom Eo 05 is -0.69
What is the cash to sales ratio of Cellectis Nom Eo 05?
The cash to sales ratio of Cellectis Nom Eo 05 is 7.5
What is the reporting currency for Cellectis Nom Eo 05?
Cellectis Nom Eo 05 reports financial results in USD
What is the latest annual turnover for Cellectis Nom Eo 05?
The latest annual turnover of Cellectis Nom Eo 05 is USD 9.24M
What is the latest annual profit for Cellectis Nom Eo 05?
The latest annual profit of Cellectis Nom Eo 05 is USD -101.06M
What is the registered address of Cellectis Nom Eo 05?
The registered address for Cellectis Nom Eo 05 is 8 RUE DE LA CROIX- JARRY, PARIS, PARIS, 75013
What is the Cellectis Nom Eo 05 website address?
The website address for Cellectis Nom Eo 05 is www.cellectis.com
Which industry sector does Cellectis Nom Eo 05 operate in?
Cellectis Nom Eo 05 operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MLSMLSmalto
0.021 €
(50.00%)
10k
GTRDSGroupe Tera DS
0.0835 €
(42.74%)
24.05k
ALMASMastrad
0.0106 €
(32.50%)
9.92M
ALWTROsmosun SA
2.35 €
(29.55%)
32.18k
ALTBGBlockchain GP
0.381 €
(24.92%)
7.1M
DRVDSDrone Volt DS
0.0018 €
(-53.85%)
571k
ALCYBCybergun
0.0001 €
(-50.00%)
7.74M
DMSBSDiagnostic Medical Systems
0.004 €
(-46.67%)
726
ALALOAcheterLouerFR
0.06 €
(-29.33%)
199.61k
MLOCTOctopus Biosafety
0.23 €
(-24.34%)
5.1k
ATOAtos SE
0.002 €
(0.00%)
1.13B
ALVERVergnet
0.0015 €
(0.00%)
113.13M
BCPBanco Comercial Portugues SA
0.5072 €
(1.68%)
35.23M
ALHPIHopium SA
0.0036 €
(-7.69%)
10.16M
ALMASMastrad
0.0106 €
(32.50%)
9.92M

最近閲覧した銘柄